Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Interesting Day yesterday...
Kratom is an herbal, plant-based substance that can not only relieve pain, and treat mood disorders, but can also help them get past their addictions.
Polyoxyfen is a provisional patent pending, product formulation (USPTO Patent Pending Application No. 62464423)
Cebidiofen
Cebidiofen is a provisional patent pending, product formulation (USPTO Patent Pending Application No. 62464442) for a pharmaceutical food made from an NSAID alternative and botanical extract blends containing cannabidiol and kava tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).
Polyoxyfen
Polyoxyfen is a provisional patent pending, product formulation (USPTO Patent Pending Application No. 62464423) for a pharmaceutical food made from an NSAID alternative and a botanical extract blends containing mitragyna speciose tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).
Source: https://hadvinc.com/products-pipeline
$HADV News Out!! Health Advance Appoints New Executive Managers and Discloses New Events
COLORADO SPRINGS, Colo., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Yesterday Health Advance Inc. (OTC PINK:HADV) filed a Form 8-K Report, adopting a new Board Resolution to appoint new executive managers and officers of the Company to take effect immediately.
The Company has appointed Chairman and Executive Director, Greg Shusterman as the new Acting President of Health Advance Inc. Shusterman was appointed as Director and Vice Chairman at Health Advance in 2017 and was the Acting Chairman and Executive Director through January 2018. Before joining Health Advance he served as a consultant to national robotic surgical clinics MiVIP Surgery Centers and oBand Inc. Additionally, Shusterman was co-founder and Executive Vice President at Gubagoo Inc., a leading customer communications solution platform serving thousands of clients including Ford, Fiat, Chrysler, BMW, Volkswagen, Kia and Land Rover. His entrepreneurial experience has helped bring start-up companies through growth and expansion phases, to maturity and exit.
Furthermore, the Company has appointed Board Director, Christian Diesveld as Vice President of Investor Relations who will assist the Company with fund-raising goals. Diesveld previously worked various senior leadership positions for a number of companies, including, but not limited to, Hantian Labs Limited, a pending acquisition of the Company, where Mr. Diesveld was recently named UK CEO of the Year - Small Enterprise in the Health and Wellness sector. Additionally, Diesveld brings over twenty years experience in capital markets, specializing in private equity and venture capital with FCA licensed firms. Diesveld attended York University where he majored in International Business and worked at Nesbitt Burns as an Investment Advisor.
Micro Medtech Ltd. remains active with the Company under a license agreement, working on developing two patented medical food formulations derived from NSAID alternatives and botanical extract blends that contain kava, cannabidiol ("CBD"), and mitragyna speciosa (better known as kratom)- Med-patents, known as Polyoxyfen and Cebidiofen. An exhibit from the recent most quarterly report for the Company filed in December displayed that there are plans for clinical trials and a medical research program titled KLEAN beginning early this year at a government accredited medical college in Pohnpei, Micronesia.
For more information about Health Advance visit www.hadvinc.com and www.staycleanmed.com.
Media Relations Contact:
media@hadvinc.com
Source: http://www.nasdaq.com/press-release/health-advance-appoints-new-executive-managers-and-discloses-new-events-20180117-00151
Cebidiofen & Polyoxyfen $HADV, in my opinion, this will only serve to benefit HADV and MMT
CBD Kratom's Customers Swear By Its Product. The Feds Want to Make It Illegal
On Morganford Road in Tower Grove South, between a fitness studio and a sports bar, sits CBD Kratom. What at least a few neighbors have mistaken for a large pot leaf is decaled on the store's window. Written in chalk on the sign out front are the questions, "In Pain? Anxious?"
Source: https://www.riverfronttimes.com/stlouis/cbd-kratom-customers-swear-by-its-product-the-feds-want-to-make-it-illegal/Content?oid=13161761
Last @ $0.05650 +(8.65%)
Real-Time Best Bid & Ask
0.056 / 0.07 (1 x 1)
Looking Good! BID @ $0.05650
2018 starting off on the right track.
Source: https://www.otcmarkets.com/stock/HADV/quote
In November 2017 Dr. Hong was appointed the Head of Project KLEAN, a cooperative founded by New Tokyo Medical College, Micro Medtech, and Health Advance in efforts to develop opioid alternatives.
Dr. Christian Hong - Clinical Research Adviser, Project KLEAN
Dr. Hong currently serves as the President of New Tokyo Medical College in Micronesia and is a former AMEDD (Army Medical Department) officer, Dr. H. Christian Hong was nominated by Board of Regents on May 2012 to serve as president of New Tokyo Medical College. His nomination was confirmed by the Board of Regents the same month and he was sworn in as the first president of New Tokyo Medical College.
Prior to his New Tokyo Medical College appointment, Dr. H. Christian Hong served as Chief of Immunology, Brooke Army Medical Center (BAMC), San Antonio, Texas. Other assignments include Principal Investigator (as a Captain) at Department of Radiation Medicine, Armed Forces Radiobiology Research Institute, Uniformed Services University, Bethesda, Maryland, and Captain, Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington, District of Columbia.
Dr. Hong holds Diploma from U.S. Army Academy of Health Sciences; graduate and doctorate degree from New York Medical College, New York and Nova Southeastern University, Florida respectively. Additionally, he holds a professional degree in medicine. Dr. Hong was awarded Meritorious Service Medal, Joint Service Commendation Medal, Army Commendation Medal, and Army Achievement Medal.
Note: Good Info some may not have seen yet on the website
Source: https://hadvinc.com/about-us
$HADV Company Overview
Health Advance Inc. is a Wyoming corporation trading on OTC Markets under ticker symbol HADV. The company operates within the U.S. and Asia-Pacific as a developer and researcher for biotechnology, primarily focused on medical foods to treat pain and other severe illnesses usually treated with pharmaceutical drugs derived from opioids, in addition to developing dietary supplements to serve as alternatives for medicine. Our strategy is to attract opportunities in the health care industry through the development of patented product formulations for medical foods Cebidofen and Polyoxyfen , and Gynspeq , a food additive made from botanical extract blends that include kava and mitrigyna speciosa. Furthermore, the Company will explore ways to use the product formulations through research studies and clinical trials with medical schools, research organizations, hospitals, and government agencies.
Source: https://hadvinc.com/about-us
As of Friday HADV or Health Advance is in Good Standing on OTCMakets.com or the Pinksheets again.
Its a NEW Year, New Management, I am looking forward to a great year and some updates on
Cebidiofen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464442
and
Polyoxyfen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464423)
The potential use of this for Opiate withdrawal OR an alternative to Opiates in the first place is epic, BOTH is even better.
I personally dont see them on the Pinks long, its a great place for venture and other initial capital raises but long term the next step of course is migrate and uplist or get bought out by a major after clinical trials and the other usual process are initiated or completed.
In my opinion, Any way you look at HADV, the "UPSIDE Potential" is great!!
HUGE Plans for HADV!!!
http://hadvinc.com OR try Google for Polyoxyfen
Cebidiofen
Cebidiofen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464442) for a pharmaceutical food made from Ibuprofen and a botanical extract blends containing cannabidiol and kava tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).
Polyoxyfen
Polyoxyfen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464423) for a pharmaceutical food made from Ibuprofen and a botanical extract blends containing mitragyna speciose tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).
$HADV No more shares on SALE for 2017! Regular Pricing commences Jan 2, 2018
Get discounted prices while you still can.
As I read the filings to me it is looking Great for 2K18 !!
You make some VERY VERY BOLD statements that are not backed up by facts.
WHERE are you getting this information from?
You are naming names and making claims that are either completely false, deceptive or based on inside information or a combintion.
Where are you getting your information?
Sounds like you are getting or were getting inside information from Starkman. Maybe you are unable to reach Starkman because his "leaks" have been plugged by the authorities because what you keep stating is not backed up by facts.
Also, from reading the company filings, the statements YOU have made have turned out to be FALSE and misleading and probably "an inducement of insider trading". YOU may have some explaining to do yourself of your source of information because CLEARLY it is not from public filings, public press releases or other public and verifiable information.
I have looked at and read all the filings and your claims are false!!!
Maybe the same Starkman you are confusing with the Rimrock Gold Corp one?
That does NOT look like a real winner you describe. https://finance.yahoo.com/q?s=RMRK
NEWS: $HADV Health Advance Submits Multiple Filings to SEC in Efforts to Bring the Company Current Following Change in Management
2018 Here we come!!!
COLORADO SPRINGS, Colo., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Recently Health Advance Inc. (OTC PINK:HADV) submitted multiple filings to EDGAR bringing the Company current on federal filing requirements and satisfying requests made by the SEC in August. The filings include disclosure about the exit of the former President of the Company, recent legal action, change of fiscal year-end and the quarterly report for September 30, 2017, and changes in control and management.
Thus, the multiple filings of Form 8-K amendments and the 10-Q quarterly report bring the Company current on all filing requirements and will allow the company to proceed forward into its new fiscal year-end of March 31, 2018.
Micro Medtech Ltd. remains active with the Company under a license agreement, working on developing two patented medical food formulations derived from NSAID alternatives and botanical extract blends that contain kava, cannabidiol ("CBD”), and mitragyna speciosa (better known as kratom)- Med-patents, known as Polyoxyfen and Cebidiofen.
For more information about Health Advance visit http://www.hadvinc.com and http://www.staycleanmed.com.
Media Relations Contact:
media@hadvinc.com
Phone: 719-466-6699
Source: https://finance.yahoo.com/news/health-advance-submits-multiple-filings-202806073.html
#ALERT !! 8K FILLED $HADV Health Advance Inc.
Mr. Jordan Starkman has resigned from the Board of Directors of HADV (the 'Board'), as well as from the position of Board Executive, President, and Director with his resignation taking effect from November 1, 2017
and LOTS more....
Source: https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12393571
HADV - Solution? - Opioid addiction is the biggest drug epidemic in U.S. history. How’d we get here?
Every day brings another story about the depth of the country’s opioid crisis. A rise of pain killer prescriptions from doctors and a pharmaceutical industry eager to boost sales in the 1990s sparked a wave of addiction that shot up by almost 500 percent in the last 15 years. As a prologue to our series covering the opioid crisis, “America Addicted,” William Brangham reports on how we got here. Click here for FULL
Source: https://www.pbs.org/newshour/show/opioid-addiction-biggest-drug-epidemic-u-s-history-howd-get
Great Video on Opioid Addiction, Just more info on why HADV is going to be strategically positioned to help individuals with this epidemic sweeping the planet today
https://www.newsy.com/stories/painkiller-alternatives-offered-to-prevent-opioid-addiction/
Keywords: #OXY #Addiction #Opiates #Opioids #Withdrawl #HADV #Solutions
Health Advance Inc (HADV) Under the Watchful Eye of Investors
Health Advance Inc (HADV) shares have sparked the interest of some chartists as the Money Flow Index has climbed above 60, potentially heading for key 70 levels. The Money Flow Index is an indicator that utilizes the volume and volatility of an asset to determine the buying or selling pressure of an asset. The indicator was developed by Avrum Soudack and Gene Quong as a volume-weighted variation of the RSI.
The Money Flow Index is calibrated from 0 to 100, and creates a money flow ratio (Positive Money Flow to Negative Money Flow) over a time period. This money flow ratio is what is pushed into an RSI formula to create a momentum indicator. Being a momentum indicator, the Money Flow Index (MFI) is capable evaluating overbought and oversold market conditions, using values of 70-80 and above for overbought conditions and 20 and below for oversold situations.
When undertaking stock analysis, investors and traders may choose to view multiple technical levels in addition to the MFI. Health Advance Inc (HADV) currently has a 14-day Commodity Channel Index (CCI) of 48.03. Investors and traders may use this indicator to help spot price reversals, price extremes, and the strength of a trend. Many investors will use the CCI in conjunction with other indicators when evaluating a trade. The CCI may be used to spot if a stock is entering overbought (+100) and oversold (-100) territory.
Source: [url]https://melvillereview.com/health-advance-inc-hadv-under-the-watchful-eye-of-investors/404046/
[/url][tag]https://melvillereview.com/health-advance-inc-hadv-under-the-watchful-eye-of-investors/404046/[/tag]
Tags: Including $HADV $GWPH $TWMJF $APHQF $ACBFF $AXIM $CRBP $MJNA
HEALTH ADVANCE INCORPORATED (OTCMKTS:HADV)’s shares fetched interest from OTC traders lately as its stock price moved $0.003, reaching the $0.129 level after last close. Companies are ranked as per their market caps, divided into mid-cap, small-cap and large-cap segments.
HEALTH ADVANCE INCORPORATED’s shares price has recorded $-16.08 month over month. Its short interest is recorded at 12,000 with as many as 0 days to close the position, against 14,300 in preceding month.
Source: https://weeklyregister.com/today-health-advance-incorporated-hadv-stock-is-in-investors-focus/
Tags: Including $HADV $GWPH $TWMJF $APHQF $ACBFF $AXIM $CRBP $MJNA
Wilder Moving Average Recorded Below the Simple Moving Average for Health Advance Inc (HADV)
Tracking the signals for Health Advance Inc (HADV), we have seen that the twenty one day Wilder Moving Average is presently below the fifty day Simple Moving Average. Traders following this line may be looking for potential sluggish near-term momentum.
Traders may be narrowing in on the ATR or Average True Range indicator when reviewing technicals. At the time of writing, Health Advance Inc (HADV) has a 14-day ATR of 0.01. The average true range indicator was created by J. Welles Wilder in order to measure volatility. The ATR may assist traders with figuring out the strength of a breakout or reversal in price. It is important to note that the ATR was not designed to determine price direction or to predict future prices.
Source: https://6milestandard.com/trading-scan-wilder-moving-average-recorded-below-the-simple-moving-average-for-health-advance-inc-hadv/203274/
Zeroing in on Yesterday’s High Point: Health Advance HADV
Health Advance Inc (HADV)’s high, the highest trade price for the day, was $0.029, while the lowest trade price for the day was $0.029. Change is the difference between the current price and the previous day’s settlement price. Change is the basis for describing and measuring data over a specific period of time. A negative change indicates declining performance while a positive change indicates an improved performance. Interpretation of change can be left to the analyst.
Source: https://nlrnews.com/zeroing-in-on-yesterdays-high-point-health-advance-inc-hadv/227361/
Shares Seesawing on Volume: Health Advance (HADV)
Shares of Health Advance Inc (HADV) are moving on volatility today 80.59% or 0.014 from the open. The OTC listed company saw a recent bid of 0.0307 and 17500 shares have traded hands in the session.
Dealing with the ups and down of the stock market is something that most investors will encounter at some point. Everyone wants to feel that thrill of seeing that big winner soar, and nobody wants to see that loser keep sinking. Figuring out how to best approach the stock market can take up a lot of time and energy. There are many strategies that investors can use when purchasing stocks for the portfolio. Some of these strategies may be riskier than others. Determining a comfortable level of risk appetite may be highly important for the individual investor. It is important to remember that there are no guarantees in the stock market. New investors may have to learn that there is rarely any substitute for hard work and tireless research. Many investors jump in head first and find this out the hard way. Realizing that there is no guaranteed strategy for stock picking might help the investor stay focused and grounded while building up the portfolio.
Source: https://nlrnews.com/zeroing-in-on-yesterdays-high-point-health-advance-inc-hadv/227361/
Technical Radar: SuperTrend Seen Above Stock Price for Health Advance Inc (HADV)
Tracking shares of Health Advance Inc (HADV), we have noted that the SuperTrend is currently higher than recent stock price levels. Active traders might be following the signal in order to determine if the stock has entered into a buying territory.
The Relative Strength Index (RSI) is a highly popular momentum indicator used for technical analysis. The RSI can help display whether the bulls or the bears are currently strongest in the market. The RSI may be used to help spot points of reversals more accurately. The RSI was developed by J. Welles Wilder. As a general rule, an RSI reading over 70 would signal overbought conditions. A reading under 30 would indicate oversold conditions. As always, the values may need to be adjusted based on the specific stock and market. RSI can also be a valuable tool for trying to spot larger market turns. Health Advance Inc (HADV) has a 14-day RSI of 39.02, the 7-day is at 36.73, and the 3-day is resting at 24.16.
Source: https://lenoxledger.com/technical-radar-supertrend-seen-above-stock-price-for-health-advance-inc-hadv/
Starkman, FORMER President and Director - 8.01 from Filing
BACKGROUND AND FACTS OF DISCUSSION RELATED TO SECTION 8 - 8.01
Health Advance, a corporation held in the State of Wyoming declares that the following facts are pursuant to the laws of Wyoming (hereafter referred to as “WYO Code”).
It is factual that the control stock shareholder, Micro Medtech, who held approximately 62% of the Company at the time of Health Advance shareholder voting, called upon special meetings held on April 8, 2017, and on April 18, 2017. The purposes of the special meetings were due to an emergency, and held pursuant to WYO Codes 17-16-702 Title 17, Chapter 16-207 and 16-303 under the Wyoming Business Corporation Act.
On the special meeting of April 8, 2017, Mr. Shusterman was elected as the Vice Chair by two shareholder votes; Micro Medtech and Starkman. The special meeting was led by (then Chair/CEO) Starkman and was conducted pursuant to WYO Code 17-16-728.
The Control Stock Committee (Voting Group) was formed pursuant to WYO Code 17-16-725 and Mr. Shusterman served as an inspector of this election and each election thereafter, as (then) director and Vice Chair of Health Advance Inc., which is pursuant to WYO Code 17-16-729.
In accordance with WYO Code 17-16-731 the voting agreements were completely enforceable with a minimum of two shareholders of a voting group signing an agreement for that purpose. The original articles of incorporation and bylaws of the Company do not state otherwise.
Starkman's past activities as CEO/Chairman of Health Advance prior to his forced leave of absence on April 18, 2017, and his removal as CEO/President/Chairman of Health Advance on June 6, 2017, were not pursuant to WYO Code 17-16-801 - Requirements for and functions of the board of directors.
The Leave of Absence Notice issued by the Control Stock Committee to Jordan Starkman on April 18, 2017 was due to a state of emergency, in accordance with WYO Code 17-16-207 and 17-16-303, 17-16-810. Thus, the Control Stock Committee and Vice Chair, Mr. Shusterman made arrangements for the Company to remain in operation with Acting/Interim Officers and a Chairperson to fill the vacancy on the Board, in accordance with to WYO Code 17-16-810. Thus, as stated in WYO Code 17-16-808 (d), "A director may be removed by the shareholders only at a meeting called for the purpose of removing the director and the meeting notice shall state that the purpose, or one (1) of the purposes, of the meeting, is removal of the director." Additionally, WYO Code 17-16-808 (a) states, "The shareholders may remove one (1) or more directors with or without cause unless the articles of incorporation provide that directors may be removed only for cause."
There were no recitals stating that any consideration for removal of a director or officer of the Company must be handled otherwise in the original bylaws and articles of incorporation filed in 2010 by Mr. Starkman, the incorporator of the Company on record with the Wyoming Secretary of State Office.
On June 6, 2016, new corporation bylaws and resolutions were executed and subsequently filed with the State of Wyoming by Acting Chairman and Executive Director, Mr. Gregory Shusterman on behalf of Health Advance Inc.
Source: Amended 10Q Filing for the period ending April 30, 2017
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12271482
HADV NEWS Out - SEC for Most Recent Quarterly 10-Q Report
COLORADO SPRINGS, CO, Sept. 7, 2017 /PRNewswire/ - Health Advance Inc. (OTC PINKS: HADV) filed an amendment to the April 2017 quarterly report upon request from the SEC that was triggered by the, not so 180-degree transition in direction and executive management, which took place in June of this year.
Health Advance adopted a new roster of executive management in June, including seasoned physicians from Harvard University and Pfizer that are now contracted to take the Company into the future with research development and clinical trials to study alternative solutions to pharmaceutical drugs derived from opiates.
Despite some minor legal disputes with the former officer of the company in the U.S. civil court, the Company is making strides to continue works with government agencies and accredited research organizations to further the development of the patented product formulations of Polyoxyfen and Cebidiofen, two medical food product formulations derived from botanical extract blends of mitragyna speciosa (kratom), kava, and a regional regulatory program in the Micronesian Islands with ties to the U.S. for cannabidiol (CBD).
For more details about Health Advance go to www.hadvinc.com, or visit the company video overview at
YES clearly from the Filing it is.
Have a look for yourself at https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12271482
HADV - SEC Reporting - Current Game on!! Check this out!
Common Stock SEC Reporting - Current
https://www.otcmarkets.com/stock/HADV/quote
Should make for an interesting week
It Seems HEALTH ADVANCE INCORPORATED ($HADV) Will Go Up
Interested investors have been looking for information on shares of HEALTH ADVANCE INCORPORATED (OTCMKTS:HADV) after the stock moved $0.003, hitting the $0.129 price point in a recent trade.
It’s the latest price, but let’s analyze how the stock has been doing recently. In the past year, HEALTH ADVANCE INCORPORATED’s stock was big mover. According to the short interest report published recently, (HADV) had 12,000 shorted shares for 0 days to cover. The prior short interest was 14,300 for a $-16.08 change. The 52-Week High and Low are noted here. -97.09 % (High), 1,190.00 %, (Low). The stock had 582,100 average volume.
Source: https://weeklyhub.com/it-seems-health-advance-incorporated-hadv-will-go-up/
HADV Jordan Starkman Lawsuit TRO Temporary Restraining Order
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
The Company filed a civil lawsuit against former CEO/Chairman Jordan Starkman et al, CV-132-S on August 4, 2017 at U.S. District Court of Wyoming and was granted a court order for a Temporary Restraining Order and Declaratory Relief on August 7, 2017.
Source: https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12227392
$HADV Plan of Operation
The Company was incorporated on April 14, 2010 in Wyoming. The former business office (virtual office) located at 3651 Lindell Road, Suite D#155, Las Vegas, NV, 89103, which has changed to a physical office location 685 Citadel Drive East - Suite 290, Colorado Springs, CO 80909 as result to resolution(s) entered at the Board of Directors and Shareholder Minutes of Meeting on June 6, 2017 (Exhibit 98.1: Section 9).
The Company’s primary telephone number 702-943-0309 has been changed to 719-466-6699 as result to resolution(s) entered by a majority vote from the Board of Directors and Shareholder Minutes of Meeting on June 6, 2017.
The Company’s primary website and email domain name ‘healthadvanceinc.com’ has been changed to ‘hadvinc.com’ as result to resolution(s) entered at the Board of Directors and Shareholder Minutes of Meeting on June 6, 2017 (Exhibit 98.1: Section 17).
The Company’s founder Jordan Starkman, who served the Company as President, Chairman of the Board of Directors, and Director, has be removed and has been replaced by Dr. Muhammad Mukhtar, Ph.D. who will serve the Company as the (Interim) Secretary, (Non-Voting, Interim) Director, Chief Advisor for Control Stock Committee, and (Acting) Chief Executive Officer until July 31, 2017, or until a permanent replacement for Secretary and President of Company is hired, collectively are results to resolution(s) entered at the Board of Directors and Shareholder Minutes of Meeting on June 6, 2017 (Exhibit 98.1: Section 4,5, 6 and Exhibit 99.1). In addition, Mr. Starkman has been removed as Chairman and replaced by Gregory Shusterman, who was appointed as Vice Chairman in April 2017 and has served as ‘Acting Chairman’ since April 19, 2017 as a result to reason specified in Exhibit Y.
Christian Diesveld, who served the Company as a Director, has be removed and has been replaced by Dr. Hauke Kolster, Ph.D.. who will serve the Company as the (Interim) Vice President (Non-Voting, Interim) Director, collectively are results to resolution(s) entered at the Board of Directors and Shareholder Minutes of Meeting on June 6, 2017 (Exhibit 98.1: Section 8).
In addition, Domenico Pascazi was appointed as a director in March 2011. On February 12, 2013, Mr. Pascazi resigned from his position as a member of the board of directors. Mr. Pascazi’s resignation was not a result of any disagreement with the Company or its executive officers, or any matter relating to the Company’s operations, policies or practices.
Why does The http://OTCMarkets.com fail to update this informaiton and continue to post inaccurate information?
Source: https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12227392
$HADV ~ Things that make you go hmm....
So Health Advance files their 10Q and...
1. 10Q filed on Friday and someone DUMPING stock?
2. OTCMarkets refusal to update their site with factual information based on 10Q
3. OTCMarkets continues to post a "stop sign" after 10 filing made
4. The Fact that OTCMarkets.com continues with the stop sign; providing misleading info to people
These are just few things that make me go Hmmmm. Makes you wonder WHY?
I have read that 10Q. There is a lot of facts in there.
Have you read it yet?
After reading the 10Q how do you draw that conclusion, please enlighten us all...
#ALERT !! 10Q FILLED $HADV Health Advance Inc.
Excerpt from 10Q..
....On June 6, 2017 it has been resolved by a majority vote from the Board of Directors and Shareholder Minutes of Meeting on June 6, 2017 that the Company will change its Industry Classification to Research and Development in Biotechnology (541714 ) in efforts to prepare for new business ventures, partnerships, business development as a developer and manufacturer of cost-effective dietary supplements and medical foods from organic sources that contain botanical extract blends as an alternative to synthetic drugs and herbal supplements, in efforts to treat pain, cancer, opiates/alcohol withdrawal, epilepsy, PTSD, and other severe illnesses.
Source https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12227392
$HADV Health Advance Inc. ~ In other industry news, other financial results and market performance of note:
Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) closed up 21.21% on Wednesday at $7.60 with over 4.2 million shares traded by the market close and was further up slightly in afterhours trading. The company recently announced top-line results from its double-blind placebo controlled Phase 2 STAR 1 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial evaluating ZYN002 (cannabidiol [CBD] gel) in adult epilepsy patients with focal seizures.
GW Pharmaceuticals plc (NASDAQ: GWPH) recently announced financial results for the third quarter ended 30 June 2017. "I am pleased to report the NDA submission process for Epidiolex is now underway with the final sections of the submission expected to be completed in October. With a clear view now towards our anticipated approval, we are making excellent progress with preparations to ensure a highly successful launch in 2018," stated Justin Gover, GW's Chief Executive Officer. "Following the recent publication of our first Phase 3 trial in The New England Journal of Medicine, we look forward to additional Epidiolex data publications and presentations in the second half of the year.
Source: https://finance.yahoo.com/news/gw-pharmaceuticals-plc-reports-fiscal-200500100.html
Technicals Placed Under Review For Shares of Health Advance Inc (HADV)
Health Advance Inc (HADV) shares are being closely watched as the Rank Correlation Indicator has shown an upward 3 bar near-term trend, indicating that a reversal might be near. If the shares reach the +80 level, this would signify that the shares have entered overbought territory.
The indicator Spearman Rank Correlation Index’s (RCI) is a statistical oscillator based on the correlation model provided by the mathematician Charles Spearman. The indicator shows statistical relations between date and price as a correlation without the relationship between the two variables is of affine type. The idea is to find correlation between the ranks of values instead of the values themselves.
Source: https://stockpressdaily.com/technicals-placed-under-review-for-shares-of-health-advance-inc-hadv/
Sizing Up the MACDH For Health Advance Inc (HADV)
Health Advance Inc (HADV)’s MACD Histogram reading is currently above the zero line, indicating a positive chart trend for the shares. Shares recently touched 0.0399 on a recent bid, moving -0.0001 in the most recent session.
Created by Thomas Aspray in 1986, the MACD Histogram is a visual indicator of the difference between the MACD line and the Signal line, which is a default 9 period ema of the MACD line. The histogram is an oscillator that moves above and below the zero line, just as the MACD line does. Keep in mind when using this oscillator, that it takes four mathematical steps from price itself to create the 4th derivative, the histogram: Price => two ema averages => MACD line = Signal line => Histogram. Which means it lags price quite a bit. But like all derivatives of price, it’s much smoother than price itself.
If the MACD is above zero it helps confirm an uptrend; below zero and it helps confirm a downtrend. Zero line and Signal line crossovers are used as trade signals to enter and exit trending trades. Losing trade signals occur when crossovers occur in rapid succession due to choppy price action. Divergence shows when momentum is slowing, but it doesn’t indicate when a reversal will occur (if it occurs). Combing different elements of each strategy makes the indicator more useful, such as taking buy signals following a bullish divergence. Using price and trend analysis will aid in determining which signals to take, such as only taking buy signals when a long-term uptrend is in place.
Source: https://aikenadvocate.com/sizing-up-the-macdh-for-health-advance-inc-hadv/276925/
Health Advance Inc (HADV) Near-Term Moving Average Signal Update
Shares of Health Advance Inc ($HADV) are heading in a near-term positive direction as the most recent close of the company has stayed above the Balance Step. The Balance Step reading takes into account the last 5 balance points of the weekly period plotted in step formation on a daily chart.
Active traders may be zooming in on some additional technical indicators for share assessment. Currently, Health Advance Inc (HADV) has a 14-day Commodity Channel Index (CCI) of 51.24. The CCI technical indicator can be used to help determine if a stock is overbought or oversold. CCI may also be used to help discover divergences that could possibly signal reversal moves. A CCI closer to +100 may provide an overbought signal, and a CCI near -100 may offer an oversold signal.
Source: https://hiramherald.com/health-advance-inc-hadv-near-term-moving-average-signal-update/
($HADV) Sales of Legal Cannabis Products are Expected to Accelerate
According to a research report by New Frontier Data, medical cannabis sales are forecast to grow to $5.3 billion in 2017 and accounting for 67% of total cannabis sales. By 2025, medical sales in currently legal states are forecast to grow to $13.2 billion, at which point medical sales will account for 55% of all sales. Comparatively, adult-use sales in 2017 are forecast to reach $2.6 billion and rising to $10.9 billion by 2025. The report also indicates that in 2016 alone, adult-use consumers shopped once every 14 days and spent $49 per transaction. Medical consumers, by contrast, shop once every 10 days and outspend the adult-use customer by more than three-to-one or spending $136 per transaction. Invictus MD Strategies Corp. (OTC: IVITF), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), GW Pharmaceuticals plc (NASDAQ: GWPH), Cara Therapeutics Inc. (NASDAQ: CARA), Insys Therapeutics Inc. (NASDAQ: INSY).
Source: http://www.prnewswire.com/news-releases/sales-of-legal-cannabis-products-are-expected-to-accelerate-634476303.html
Health Advance Inc ($HADV) Moving 10.26% in Session
Needle moving action has been spotted in Health Advance Inc (HADV) as shares are moving today on volatility +10.26% or 0.004 from the open. The OTC listed company saw a recent bid of 0.0430 and 21300 shares have traded hands in the session.
Health Advance Inc (HADV) currently has a 14-day Commodity Channel Index (CCI) of 64.82. Active investors may choose to use this technical indicator as a stock evaluation tool. Used as a coincident indicator, the CCI reading above +100 would reflect strong price action which may signal an uptrend. On the flip side, a reading below -100 may signal a downtrend reflecting weak price action. Using the CCI as a leading indicator, technical analysts may use a +100 reading as an overbought signal and a -100 reading as an oversold indicator, suggesting a trend reversal.
Source: https://bvnewsjournal.com/health-advance-inc-hadv-moving-10-26-in-session/113557/
Health Advance (HADV) $0.0449 +0.0039 (+9.51%)
Volume: 45,190 @ 11:01:58 AM ET
Needle Action Activity Spotted in Health Advance Inc ($HADV)
Shares of Health Advance Inc (HADV) is moving on volatility today 9.76% or 0.004 rom the open. The OTC listed company saw a recent bid of 0.0450 on 3000 volume.
Source: https://tuckermantimes.com/needle-action-activity-spotted-in-health-advance-inc-hadv/234100/